Promoting use of generics andbiosimilars will be a particular focus of the group, which couldsave as much as $150 billion over the next decade. (Photo:Shutterstock)

First, there was Civica Rx, a coalition of hospitals and healthsystems intent on creating their own generic drugs to save on costsand combat supply shortages. But health systems aren't the onlyones feeling the pain of high drug prices.

Joining the fight against high drug prices is Employers'Prescription for Affordable Drugs, aka, EmployersRx, acoalition of employer groups advocating for prescription drug pricereform. Launched last fall, the group represents more than 500employers. "Someone needs to represent the sector that isactually paying most of the bill," Bill Kramer, the executivedirector for national health policy at the Pacific Business Groupon Health told STAT.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Emily Payne

Emily Payne is director, content analytics for ALM's Business & Finance Markets and former managing editor for BenefitsPRO. A Wisconsin native, she has spent the past decade writing and editing for various athletic and fitness publications. She holds an English degree and Business certificate from the University of Wisconsin.